Natco Pharma Q2 Results: Net profit surges 83%, topline and margin expand from last year

The board of Natco Pharma has announced a second interim dividend of ₹1.50 per equity share of face value of ₹2 each for the financial year 2024-25. Record date for the said dividend has been fixed as November 25, 2024.

Leave a Reply

Your email address will not be published. Required fields are marked *